TransMedics Group, Inc. SEC filings TMDX

TransMedics Group, Inc. has 630 filings in SEC EDGAR's recent list, going back to Oct 19, 2018. Its latest annual report, Form ARS, was filed on Apr 10, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Nov 5, 2026, covering the quarter ended Sep 30, 2026. The most recent current report (Form 8-K) was filed on Nov 5, 2026 (results of operations). The company's fiscal year ends on December 31.

TransMedics Group, Inc. SEC filings
Form Description Filed Period
DEFA14A Additional proxy material May 7, 2026 —
DEFA14A Additional proxy material Apr 10, 2026 —
DEF 14A Proxy statement Apr 10, 2026 May 20, 2026
DEFA14A Additional proxy material Apr 10, 2025 —
DEF 14A Proxy statement Apr 10, 2025 May 22, 2025
DEFA14A Additional proxy material Apr 10, 2024 —
DEF 14A Proxy statement Apr 10, 2024 May 23, 2024
DEFA14A Additional proxy material Apr 12, 2023 —
DEF 14A Proxy statement Apr 12, 2023 —
DEFA14A Additional proxy material Apr 22, 2022 —
DEFA14A Additional proxy material Apr 20, 2022 —
DEF 14A Proxy statement Apr 20, 2022 Jun 1, 2022
DEFA14A Additional proxy material Apr 16, 2021 —
DEF 14A Proxy statement Apr 16, 2021 May 27, 2021
DEFA14A Additional proxy material Apr 14, 2020 —
DEF 14A Proxy statement Apr 14, 2020 Jun 4, 2020

Showing 16 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

Company profile

Industry
Electromedical & Electrotherapeutic Apparatus (SIC 3845)
Listed as
TMDX (Nasdaq)
Fiscal year ends
December 31
Incorporated in
MA
Headquarters
Andover, MA
SEC filer status
Large accelerated filer
SEC CIK
1756262

Other Electromedical & Electrotherapeutic Apparatus companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.